Wed, February 21, 2024

Bill Maughan Reiterated (BCYC) at Strong Buy and Held Target at $60 on, Feb 21st, 2024

Bill Maughan of Canaccord Genuity, Reiterated "Bicycle Therapeutics plc" (BCYC) at Strong Buy and Held Target at $60 on, Feb 21st, 2024.

Bill has made no other calls on BCYC in the last 4 months.



There are 3 other peers that have a rating on BCYC. Out of the 3 peers that are also analyzing BCYC, 1 agrees with Bill's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Jeffrey Hung of "Morgan Stanley" Maintained at Hold with Decreased Target to $40 on, Friday, November 3rd, 2023


These are the ratings of the 2 analyists that currently disagree with Bill


  • Reni Benjamin of "JMP Securities" Maintained at Buy with Decreased Target to $32 on, Wednesday, December 20th, 2023
  • Li Watsek of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $65 on, Wednesday, November 8th, 2023